News for ASLAN Pharmaceuticals Limited (ASLN)

Loading... Loading... The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. ` The RSI is a momentum in...

Loading... Loading... Shares of SolarEdge Technologies, Inc. SEDG fell sharply during Monday's session after the company announced a workforce reduction. Sola...

Loading... Loading... U.S. stocks traded higher midway through trading, with the Nasdaq Composite rising more than 200 points on Monday. The Dow traded up 0.7...

Loading... Loading... U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. Following the market opening Mo...

ASLAN Pharmaceuticals to be delisted from Nasdaq due to non-compliance with bid price and stockholder equity requirements.

FTC sues to block Tempur Sealy's $4B purchase of Mattress Firm. EV maker Rivian has no production plans with Volkswagen - report. Eli Lilly wins FDA approval of donanemab for Alzheimer's.

Loading... Loading... Shares of Vuzix Corporation VUZI rose sharply in today's pre-market trading after the company disclosed a strategic partnership with Aveg...

ASLAN Pharmaceuticals (ASLN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ASLAN Pharmaceuticals (ASLN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.

Read Head-To-Head Comparison: ASLAN Pharmaceuticals (NASDAQ:ASLN) versus Sophiris Bio (OTCMKTS:SPHS) at ETF Daily News

Toward the end of trading Monday, the Dow traded up 0.43% to 34,949.08 while the NASDAQ fell 0.35% to 14,995.27. The S&P also fell, dropping 0.05% to ...

Midway through trading Monday, the Dow traded up 0.70% to 35,041.74 while the NASDAQ fell 0.51% to 14,970.85. The S&P also rose, gaining 0.02%...

Following the market opening Monday, the Dow traded up 0.65% to 35,024.73 while the NASDAQ fell 0.98% to 14,899.77. The S&P also fell, dropping 0.22% to ...

PRESS RELEASE August 20, 2021 The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the... | August 20, 2021

Hagens Berman urges XL Fleet Corp. (NYSE: XL) investors with significant losses to submit your losses now. The firm is investigating possible securities law violations and certain investors may have valuable claims.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Ma...

Biotech Penny Stocks To Watch Right Now February closed out with a tumultuous week of trading in more than just penny stocks. Fears of inflation and uncertaint...